Markers of diabetes are positively associated with overactive bladder (OAB), according to a study published online April 28 in Frontiers in Endocrinology.
Jun 4, 2024
0
1
GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data presented at ...
Jun 3, 2024
0
0
Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented at ENDO 2024, ...
Jun 3, 2024
0
0
Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study presented at ENDO 2024, the Endocrine ...
Jun 3, 2024
0
2
People who have had type 1 diabetes for more than 50 years without kidney complications may still be at substantial risk for heart disease, despite excellent control of blood pressure, cholesterol and blood sugar levels, ...
Jun 1, 2024
0
1
Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study presented Saturday ...
Jun 1, 2024
0
1
One year after a prediabetes diagnosis, Asians were more likely to develop diabetes mellitus whereas Black patients were more likely to remain in prediabetes range, highlighting racial disparities in diabetes prevention, ...
Jun 1, 2024
0
11
Prediabetes increases the risk of dying before age 75, particularly due to heart disease, kidney disease and acute diabetic complications, according to a new study presented at ENDO 2024, the Endocrine Society's annual meeting ...
Jun 1, 2024
0
52
People of color and those who experience social vulnerability are more likely to experience worse glycemic control than their white counterparts, according to research presented at ENDO 2024, the Endocrine Society's annual ...
Jun 1, 2024
0
1
Testosterone appears protective against developing type 2 diabetes in men who are overweight or obese and under age 65, but not in men over that age, according to a study presented at ENDO 2024, the Endocrine Society's annual ...
Jun 1, 2024
0
1
